Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Morten Lock Hansen

Showing results (101-110 of 131) with videos related to

Pageof 14
Sort By:
BMJ (Clinical Research Ed.)|February 2, 2011
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Morten Lock Hansen, et al.
Circulation|July 25, 2007
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomesGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrom, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2008
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockersMorten Lock Hansen, Niels Gadsbøll, Gunnar H Gislason, et al.
Journal of the American College of Cardiology|June 11, 2013
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary interventionMorten Lamberts, Gunnar H Gislason, Jonas Bjerring Olesen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 7, 2012
Accuracy of the ICD-10 discharge diagnosis for syncopeMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
Journal of Cardiovascular Electrophysiology|May 17, 2024
Effect of early cryoballoon ablation on atrial fibrillation recurrence-A Danish nationwide register studyRegitze Hein, Lise Da Riis-Vestergaard, Jacob Tønnesen, et al.
The American Journal of Medicine|December 3, 2021
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or DabigatranAnders Holt, Jarl E Strange, Peter Vibe Rasmussen, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
International Journal of Cardiology|April 26, 2022
Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablationAnne Bjerg Nielsen, Kristoffer Grundtvig Skaarup, Kasper Djernæs, et al.
BMJ Open|May 7, 2013
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyRikke Sørensen, Gunnar Gislason, Christian Torp-Pedersen, et al.
Pageof 14

Showing results (101-110 of 131) with videos related to

Sort By:
Pageof 14
BMJ (Clinical Research Ed.)|February 2, 2011
Validation of risk stratification schemes for predicting stroke and thromboembolism in patients with atrial fibrillation: nationwide cohort studyJonas Bjerring Olesen, Gregory Y H Lip, Morten Lock Hansen, et al.
Circulation|July 25, 2007
Persistent use of evidence-based pharmacotherapy in heart failure is associated with improved outcomesGunnar H Gislason, Jeppe N Rasmussen, Steen Z Abildstrom, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 9, 2008
Atrial fibrillation pharmacotherapy after hospital discharge between 1995 and 2004: a shift towards beta-blockersMorten Lock Hansen, Niels Gadsbøll, Gunnar H Gislason, et al.
Journal of the American College of Cardiology|June 11, 2013
Oral anticoagulation and antiplatelets in atrial fibrillation patients after myocardial infarction and coronary interventionMorten Lamberts, Gunnar H Gislason, Jonas Bjerring Olesen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 7, 2012
Accuracy of the ICD-10 discharge diagnosis for syncopeMartin Huth Ruwald, Morten Lock Hansen, Morten Lamberts, et al.
Journal of Cardiovascular Electrophysiology|May 17, 2024
Effect of early cryoballoon ablation on atrial fibrillation recurrence-A Danish nationwide register studyRegitze Hein, Lise Da Riis-Vestergaard, Jacob Tønnesen, et al.
The American Journal of Medicine|December 3, 2021
Bleeding Risk Following Systemic Fluconazole or Topical Azoles in Patients with Atrial Fibrillation on Apixaban, Rivaroxaban, or DabigatranAnders Holt, Jarl E Strange, Peter Vibe Rasmussen, et al.
BMC Cardiovascular Disorders|July 16, 2024
A danish healthcare-focused economic evaluation of first-line cryoballoon ablation versus antiarrhythmic drug therapy for the treatment of paroxysmal atrial fibrillationMorten Lock Hansen, Joe W E Moss, Jacob Tønnesen, et al.
International Journal of Cardiology|April 26, 2022
Left atrial contractile strain predicts recurrence of atrial tachyarrhythmia after catheter ablationAnne Bjerg Nielsen, Kristoffer Grundtvig Skaarup, Kasper Djernæs, et al.
BMJ Open|May 7, 2013
Dabigatran use in Danish atrial fibrillation patients in 2011: a nationwide studyRikke Sørensen, Gunnar Gislason, Christian Torp-Pedersen, et al.
Pageof 14